Paper Details

  1. Home
  2. Paper Details

[Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].

Author: IshiharaT, NakamuraH, SanoT, TezukaT, ToyonagaY

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cefditoren pivoxil (CDTR-PI) is a new oral cephalosporin with high antibacterial activity against common pediatric pathogens. It was absorbed well and had a dose-dependent pharmacokinetic profile. In a clinical trial, CDTR-PI was effective in 97.5% of patients with various infections, including bronchitis, pneumonia, tonsillitis, scarlet fever, impetigo, otitis media and UTIs. Side effects were minimal.
Paper Details　
Original Abstract of the Article :
Bacteriological, pharmacokinetic and clinical studies on cefditoren pivoxil (CDTR-PI, ME 1207) in granules, a new oral cephalosporin, were performed in the field of pediatrics. The results are summarized below. 1. Antibacterial activities: Antibacterial activities of CDTR were studied against Staphy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8371496

データ提供：米国国立医学図書館（NLM）

Cefditoren Pivoxil: A New Cephalosporin for Pediatric Patients

The world of antibiotics is a vast and intricate desert, filled with diverse microorganisms and their unique characteristics. This study explores the potential of cefditoren pivoxil (CDTR-PI) as a new oral cephalosporin for treating infections in children.

Researchers are conducting bacteriological, pharmacokinetic, and clinical studies to assess the effectiveness of CDTR-PI in children. This is like exploring a new oasis in the desert, carefully examining its properties and potential benefits.

Effectiveness of CDTR-PI

The study demonstrates the high antibacterial activity of CDTR-PI against common pathogens in children, suggesting its potential for treating a range of infections. CDTR-PI's absorption, excretion, and clinical efficacy are also investigated, providing valuable insights for safe and effective use.

Navigating the Desert of Pediatric Infections

This research offers a potential solution to the challenges of treating infections in children. By understanding the efficacy and safety of CDTR-PI, clinicians can navigate the desert of pediatric infections with greater confidence.

Dr. Camel's Conclusion

This study provides valuable information about a new antibiotic for pediatric patients. It represents a step forward in the ongoing quest to find safe and effective treatments for infections in children, offering hope for a brighter future in the challenging desert of pediatric healthcare.

Date :
  1. Date Completed 1993-10-08
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

8371496

DOI: Digital Object Identifier

8371496

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.